About Cenforce Australia
Cenforce Australia is a Healthcare company. Online supply of erectile dysfunction medications in Australia. The company has 279 employees. Its Indian entity Centurion Laboratories Private Limited reported revenue of ₹208 Cr. Cenforce Australia offers products and services including Cenforce Tablets and Other Generics. Its focus areas include Pharmaceuticals, General Medications, Generic Drugs and ED Treatments.
Company details
Cenforce is produced by Centurion Laboratories and is distributed online in Australia as a generic alternative to Viagra, containing sildenafil citrate for treating erectile dysfunction. Various dosages from 25 mg to 200 mg are offered, with recommendations based on medical consultation to ensure safety. The medication is known for enhancing blood flow to achieve erections, and its affordability makes it accessible, though side effects like headaches and dizziness are noted. Overall, it is positioned as an effective option under professional guidance, with purchases handled discreetly through online platforms.
- Employees 279
- SectorsHealthcare
- Website cenforce-australia.com
- Legal Name Centurion Laboratories Pvt Ltd
- Date of Incorporation 21 Dec, 2006
- Jurisdiction Vadodara, Gujarat, India
- Indian entity revenue₹208 Cr
FY 2024 · +35% YoY
- Indian entity net profit₹10.91 Cr
FY 2024 · 5% margin
- Indian entity EBITDA₹18.52 Cr
FY 2024 · 9% margin
- Employee Count279
Associated legal entities of Cenforce Australia
Cenforce Australia operates through Centurion Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Centurion Laboratories Private Limited CIN U73100GJ2006PTC049620 | Active | 21 Dec 2006 | Vadodara, Gujarat | ₹208 Cr | 289 | 2 | View details |
Products & Services of Cenforce Australia
Cenforce Australia offers a comprehensive portfolio of products and services, including Cenforce Tablets and Other Generics.
Sildenafil citrate tablets are provided for the management of erectile dysfunction across various dosages
Additional generic medications such as Vidalista and Kamagra are supplied for related health conditions
Board of directors of Centurion Laboratories Private Limited (Cenforce Australia)
Centurion Laboratories Private Limited is the primary company behind Cenforce Australia. The board of Centurion Laboratories Private Limited currently have 2 directors; the longest-serving is Mahipat Ambalalbhai Patel, appointed in 2013. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahipat Ambalalbhai Patel DIN 06373494 | Director | 20 Feb 2013 | 13 yrs 8 mo | Centurion Laboratories Private Limited |
| Chandrakant Patel DIN 10943787 | Additional Director | 01 Apr 2025 | 1 yr 7 mo | Centurion Laboratories Private Limited |
Financials of Cenforce Australia
Figures of Centurion Laboratories Private Limited, the primary company behind Cenforce Australia, for FY 2024. Revenue was ₹208 Cr (+35% year on year). Net profit was ₹10.91 Cr (5% margin). EBITDA was ₹18.52 Cr (9% margin). Revenue has grown at a compounded annual rate of +24% over three years and +23% over five years.
- ₹208 CrRevenue · FY 2024 · +35% YoY
- ₹10.91 CrNet profit · 5% margin
- ₹18.52 CrEBITDA · 9% margin
- ₹4.00 CrPaid-up capital
- 289Employees (provident fund records)
- +24%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Centurion Laboratories Private Limited are on its company page.
Detailed financial statements for Cenforce Australia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cenforce Australia
Cenforce Australia has 279 employees.
The primary company behind Cenforce Australia, Centurion Laboratories Private Limited, reported revenue of ₹208 Cr for FY 2024, up 35% year on year.
Cenforce is produced by Centurion Laboratories and is distributed online in Australia as a generic alternative to Viagra, containing sildenafil citrate for treating erectile dysfunction. Various dosages from 25 mg to 200 mg are offered, with recommendations based on medical consultation to ensure safety. The medication is known for enhancing blood flow to achieve erections, and its affordability makes it accessible, though side effects like headaches and dizziness are noted. Overall, it is positioned as an effective option under professional guidance, with purchases handled discreetly through online platforms.
Cenforce Australia offers Cenforce Tablets and Other Generics.
Cenforce Australia operates through Centurion Laboratories Private Limited.
The legal entities of Cenforce Australia currently have 2 directors, including Mahipat Ambalalbhai Patel, Chandrakant Patel.